ProteinSimple Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 200

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $300M

ProteinSimple General Information

Description

Provider of nano-proteomic analysis systems designed to resolve protein analysis problems. The company's system and software and assay products used for measurement of phosphor-protein signaling and activation in small biological samples, enabling life science researchers to quantify phosphor-protein isoforms in cells and tissues, measuring signaling proteins in primary and sorted stem cells and monitoring drug actions in tissue sections and fine needle aspirates.

Contact Information

Formerly Known As
Signal Analytics, Cell Biosciences
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 3001 Orchard Parkway
  • San Jose, CA 95134
  • United States
Primary Industry
Decision/Risk Analysis
Acquirer
Vertical(s)
Corporate Office
  • 3001 Orchard Parkway
  • San Jose, CA 95134
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProteinSimple Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 31-Jul-2014 $300M Completed Generating Revenue
7. IPO 01-May-2014 Cancelled Generating Revenue
6. Later Stage VC (Series F) 13-May-2011 Completed Generating Revenue
5. Later Stage VC (Series E) 17-Dec-2009 Completed Generating Revenue
4. Later Stage VC (Series D) 11-Nov-2009 Completed Generating Revenue
3. Later Stage VC (Series C) 16-Apr-2009 Completed Generating Revenue
2. Early Stage VC (Series B) 09-Nov-2006 $26.9M $41.3M Completed Generating Revenue
1. Early Stage VC (Series A) 13-Jul-2005 $14.4M $14.4M Completed Generating Revenue
To view ProteinSimple’s complete valuation and funding history, request access »

ProteinSimple Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series F
Series E
Series D
Series C
Series B 17,935,800 $0.000100 $0.12 $1.5 $1.5 1x $1.5 11.26%
Series A 14,420,000 $0.000100 $0.08 $1 $1 1x $1 9.05%
To view ProteinSimple’s complete cap table history, request access »

ProteinSimple Patents

ProteinSimple Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025250758-A1 System and method for protein quantification with parallelized capillary-electrophoresis immunoassays Pending 31-May-2024
WO-2025230863-A1 Systems and methods for improved tracking, fractionation, collection, and identification of analytes in a sample Pending 29-Apr-2024
EP-4396571-A1 Methods and systems for analysis of samples containing particles used for gene delivery Pending 03-Sep-2021
US-11535900-B1 Methods and systems for analysis of samples containing particles used for gene delivery Active 03-Sep-2021
US-11827946-B2 Methods and systems for analysis of samples containing particles used for gene delivery Active 03-Sep-2021 G01N27/44795
To view ProteinSimple’s complete patent history, request access »

ProteinSimple Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProteinSimple Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Domain Associates Venture Capital Minority
EW Healthcare Partners Growth/Expansion Minority
Lansing Brown Investments Venture Capital Minority
Latterell Venture Partners Venture Capital Minority
Mitsui Global Investment Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

ProteinSimple Acquisitions (4)

ProteinSimple’s most recent deal was a Merger/Acquisition with Brightwell Technologies for . The deal was made on 12-May-2011.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Brightwell Technologies 12-May-2011 Merger/Acquisition Other Healthcare Technology Systems
Convergent Bioscience (Devices and Supplies) 31-Oct-2010 Merger/Acquisition Other Devices and Supplies
Protein Forest 07-Dec-2009 Merger/Acquisition Other Devices and Supplies
Alpha Innotech 28-Oct-2009 Merger/Acquisition Diagnostic Equipment
To view ProteinSimple’s complete acquisitions history, request access »

ProteinSimple FAQs

  • When was ProteinSimple founded?

    ProteinSimple was founded in 2004.

  • Where is ProteinSimple headquartered?

    ProteinSimple is headquartered in San Jose, CA.

  • What is the size of ProteinSimple?

    ProteinSimple has 200 total employees.

  • What industry is ProteinSimple in?

    ProteinSimple’s primary industry is Decision/Risk Analysis.

  • Is ProteinSimple a private or public company?

    ProteinSimple is a Private company.

  • What is the current valuation of ProteinSimple?

    The current valuation of ProteinSimple is .

  • What is ProteinSimple’s current revenue?

    The current revenue for ProteinSimple is .

  • How much funding has ProteinSimple raised over time?

    ProteinSimple has raised $109M.

  • Who are ProteinSimple’s investors?

    Domain Associates, EW Healthcare Partners, Lansing Brown Investments, Latterell Venture Partners, and Mitsui Global Investment are 5 of 10 investors who have invested in ProteinSimple.

  • When was ProteinSimple acquired?

    ProteinSimple was acquired on 31-Jul-2014.

  • Who acquired ProteinSimple?

    ProteinSimple was acquired by Bio-Techne.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process